-
HEALTHCARE ACCESS AND BARRIERS AMONG RURAL POPULATIONS IN INDIA: A NARRATIVE REVIEW OF PATIENT-CENTERED AND ECONOMIC OUTCOMES
Aug 11, 2026, 17:16 PM -
COST UTILITY ANALYSIS OF OBINUTUZUMAB BETA VERSUS OBINUTUZUMAB FOR PRIMARY MEMBRANOUS NEPHROPATHY IN CHINA: A MAIC-ADJUSTED MARKOV MODEL ANALYSIS
Aug 11, 2026, 17:16 PM -
EVALUATION OF ARTIFICIAL INTELLIGENCE TOOLS FOR THE CONSIDERATION OF AUTOMATION OR AUGMENTATION OF LITERATURE REVIEW PROCESSES AT NICE: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
ACCELERATING REAL-WORLD EVIDENCE STUDIES THROUGH AI-ASSISTED EVIDENCE INTEGRATION
Aug 11, 2026, 17:16 PM -
CAN MCDA INFORMED AI IMPROVE CONSISTENCY IN HTA DECISIONS
Aug 11, 2026, 17:16 PM -
ORGANIZATIONAL AND BUDGET IMPACT IN FRANCE OF A SALIVA MICRORNA TEST FOR ENDOMETRIOSIS
Aug 11, 2026, 17:16 PM -
ENVIRONMENTAL EXTERNALITIES IN HEALTHCARE PROVISION: EVIDENCE FROM A DANISH SUPPLY CHAIN ANALYSIS
Aug 11, 2026, 17:16 PM -
ACCURACY AND EFFICIENCY OF A HUMAN-IN-THE-LOOP PROMPT-FEEDBACK WORKFLOW FOR ARTIFICIAL INTELLIGENCE-ENABLED EVIDENCE SYNTHESIS: A MULTIPLE MYELOMA SYSTEMATIC LITERATURE REVIEW CASE STUDY
Aug 11, 2026, 17:16 PM -
IDENTIFICATION AND USE OF PROGNOSTIC FACTORS AND TREATMENT EFFECT MODIFIERS IN NICE TECHNOLOGY APPRAISALS: DIFFERENCES BETWEEN ONCOLOGY AND RARE DISEASES AND IMPLICATIONS FOR JCA
Aug 11, 2026, 17:16 PM -
PATIENT-REPORTED OUTCOMES AMONG COMMUNITY MENTAL HEALTH SERVICE USERS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PEMBROLIZUMAB PLUS CHEMORADIOTHERAPY VERSUS CHEMORADIOTHERAPY ALONE FOR CERVICAL CANCER IN INDIA: A MARKOV MODEL EVALUATION
Aug 11, 2026, 17:16 PM -
CONFIDENTIAL YET ACCOUNTABLE? PROTECTING COMMERCIAL DATA WHILE KEEPING EU HTA TRANSPARENT
Aug 11, 2026, 17:16 PM -
UTILISATION OF INHALED THERAPIES FOR MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN IRELAND: A RETROSPECTIVE ANALYSIS OF PRIMARY CARE CLAIMS DATA
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF OBESITY: REAL-WORLD DATA FROM THE GREEK PRIVATE HEALTHCARE SECTOR
Aug 11, 2026, 17:16 PM -
CALCIFEDIOL VERSUS CHOLECALCIFEROL IN HYPOVITAMINOSIS D: A REGIONAL COST ANALYSIS IN SPAIN
Aug 11, 2026, 17:16 PM -
THE BURDEN OF PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION: FINDINGS FROM A PSPA PATIENT AND CAREGIVER SURVEY IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
EFFICIENCY GAPS IN SUBCUTANEOUS BIOLOGIC THERAPY: A REAL-WORLD DATA ENVELOPMENT ANALYSIS
Aug 11, 2026, 17:16 PM -
DRIVERS OF NEGATIVE HTA DECISIONS IN BETWEEN ENGLAND AND IRELAND: A DATA-DRIVEN REVIEW OF COST-EFFECTIVENESS SUBMISSIONS
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE SOCIETAL VALUE OF RESMETIROM FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS USING A SOCIETAL VALUE MODELING APPROACH
Aug 11, 2026, 17:16 PM -
CLINICAL TRIAL EVIDENCE, EXPEDITED REGULATORY PATHWAYS, AND REVIEW EFFICIENCY OF RARE DISEASE DRUGS APPROVED IN CHINA, 2016-2025
Aug 11, 2026, 17:16 PM
